CompletedNCT05905367
Fentanyl induction strategy for people receiving opioid care
About this title
Read the official source — NCT05905367Medication studyAges 19+CanadaAddiction
Understand this study
Who was this study for?
Listed age limits: from 19 years.
- Listed locations
- VancouverSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateStarted: January 29, 2024
- Recruitment status
- Completed
- Enrollment listed in the registry
- 48
- Sponsor
- Pouya Azar
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Canada
- Age range
- Over 19 Years
- Official registry ID
- NCT05905367
- Official title
Show the full official title
Rapid IV Symptom-inhibited Fentanyl Induction (SIFI) to Facilitate Rotation Onto Oral Opioid Agonist Therapy (OAT)
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Vancouver
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Pouya Azar.
Did this study involve medication?
Yes. The study involved medication, including Fentanyl, Methadone and Slow-release oral morphine.
Who was this study for?
Listed age limits: from 19 years.
